We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Novel Antimicrobial Role of Intracellular Organelle

By LabMedica International staff writers
Posted on 30 Aug 2017
A recent study illustrated the importance of cellular organelles called peroxisomes to the ability of macrophages to internalize and destroy pathogenic microorganisms through phagocytosis.

Peroxisomes are organelles found in virtually all eukaryotic cells. More...
They are involved in catabolism of very long chain fatty acids, branched chain fatty acids, D-amino acids, and polyamines, reduction of reactive oxygen species – specifically hydrogen peroxide – and biosynthesis of plasmalogens, i.e., ether phospholipids critical for the normal function of mammalian brains and lungs. They also contain approximately 10% of the total activity of two enzymes in the pentose phosphate pathway, which is important for energy metabolism

Investigators at the University of Alberta Faculty of Medicine & Dentistry (Edmonton, Canada) worked with cultures of Drosophila (fruit fly) and mouse macrophages. They reported in the July 18, 2017, issue of the journal Immunity that peroxisomes were necessary for the engulfment of bacteria by these macrophages. Peroxisomes were also required for resolution of bacterial infection through canonical innate immune signaling. Reduced peroxisome function impaired the turnover of the oxidative burst necessary to fight infection.

The investigators also showed that peroxisomes could transmit to other organs evidence that an infection was in progress. Failure of the organelle to function interrupted this communication and the organism did not fight the pathogen.

"To find organelles like peroxisomes that had no link whatsoever to fighting bacterial infections was a critical discovery - it will help expand the roles of what this important organelle does in innate immunity against bacterial and fungi, and its involvement in viral signaling and the lethal peroxisome genetic diseases," said contributing author Dr. Richard Rachubinski, professor of cell biology at the University of Alberta Faculty of Medicine & Dentistry. "As the threat of bacterial infections continues to grow, this discovery can help move our understanding of immunity forward."

Related Links:
University of Alberta Faculty of Medicine & Dentistry


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
Urine Analyzer
respons® UDS100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers from the Department of Chemistry at Aarhus University have developed and tested a new technology that can identify and measure the concentration of pharmaceuticals in under 10 minutes. Today, this process takes up to an hour. That is critical waiting time for patients suffering from a stroke. (Image Credit: Aarhus University)

Point-of-Care Blood Test Could Speed Treatment Decisions in Acute Stroke

Minutes can shape treatment decisions in emergency stroke care, particularly when physicians need to know whether a patient is taking anticoagulants before administering clot-dissolving therapy.... Read more

Microbiology

view channel
Image: The clearance also broadens QIAstat-Dx\'s infectious disease testing menu in the U.S., which already includes panels for respiratory and gastrointestinal infections, as well as meningitis and encephalitis (Photo courtesy of Qiagen)

One-Hour Molecular Panel Expands Bloodstream Infection Testing for Gram-Negative Pathogens

Bloodstream infections can progress rapidly and lead to sepsis, organ failure, and death. In the United States, about 1.7 million adults develop sepsis each year, and at least 350,000 die during hospitalization... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.